Subendothelial collagen

Subendothelial collagen, primarily consisting of types I, III, and VI, is a critical component of the vascular extracellular matrix located beneath the endothelial lining (Source: StatPearls, "Physiology, Hemostasis"). Under healthy conditions, it is shielded from blood flow, but vascular injury or plaque rupture exposes it to circulating blood (Source: Journal of Thrombosis and Haemostasis, 2014). This exposure triggers platelet adhesion and activation via receptors like Glycoprotein VI (GPVI) and integrin alpha2beta1, initiating the formation of a thrombus (Source: Nature Reviews Cardiology, 2013). While essential for normal hemostasis, this process also drives pathological thrombosis in conditions like myocardial infarction and stroke (Source: Arteriosclerosis, Thrombosis, and Vascular Biology, 2012). Therapeutic agents like Revacept, a GPVI-Fc fusion protein, are designed to target exposed collagen specifically at the site of vascular damage (Source: European Heart Journal, 2021). By masking collagen binding sites, these drugs prevent platelet recruitment and subsequent arterial occlusion without significantly increasing systemic bleeding risk (Source: Journal of the American College of Cardiology, 2021). This lesion-directed approach represents a novel strategy in antiplatelet therapy, aiming to improve safety profiles compared to traditional systemic inhibitors (Source: ClinicalTrials.gov, NCT01645306).

Other names

Vascular collagenSubendothelial matrix collagenExtracellular matrix collagenLesion-exposed collagen

Competitive inhibition of platelet-collagen interactions by masking exposed collagen fibers at sites of vascular injury, thereby preventing the binding of platelet receptors such as Glycoprotein VI (GPVI) and integrin alpha2beta1 (Source: Journal of the American College of Cardiology, 2021).